MAPT and Alzheimer disease: Some studies report no correlation between TauC3 and NFT formation or cognitive decline in AD (51, 52), whereas others have shown evidence that TauC3 may help eliminate toxic tau species or inhibit hyperphosphorylated tau accumulation (53, 54).